Critical
AppleInsider
A U.S. judge has upheld Apple’s obligation to pay $634 million to Masimo, stemming from a patent infringement case related to the Apple Watch’s blood-oxygen sensor. The payment, while significant, represents a small fraction of Apple’s cash reserves. The patents involved will expire by 2029, reducing future legal exposure.
Investment implication: Although the $634M payment is financially manageable, this case highlights the legal risks tied to Apple’s health-tech ambitions. Future R&D and acquisitions in this space may require stricter intellectual property evaluations.